Position in ABSI
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$9,272
+$6,872 QoQ
Shares Held
800
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#183
of 196 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CENTRAL TRUST Co holds $4,547,131 across 18 Biotechnology names. ABSI ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,641 | $3,298,783 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,444 | $900,391 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
713 | $171,811 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
174 | $54,999 | |
| 5 | EXEL |
Exelixis, Inc.
|
541 | $29,435 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,688 | $28,645 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
356 | $27,864 | |
| 8 | ABSI |
Absci Corp
This page
|
800 | $9,272 |
All Filings in ABSI
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,272 | 800 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $2,400 | 800 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,792 | 800 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,432 | 800 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,056 | 800 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,008 | 800 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $2,096 | 800 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,056 | 800 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,464 | 800 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $4,544 | 800 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $3,360 | 800 | Shares | Sole | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||